Opinion|Videos|November 30, 2023
Potential Severe Side Effects of HER2-Positive Metastatic Breast Cancer Treatment
Author(s)Sara M. Tolaney, MD, MPH
Patients on HER2-targeted therapies for HER2-positive metastatic breast cancer should be vigilant about potential side effects like heart toxicities and interstitial lung disease and should undergo regular heart function monitoring and lung scans to catch these side effects early.
Advertisement
Episodes in this series
Advertisement
Related to this article
FDA approves Inluriyo plus Verzenio for adults with ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast cancer after endocrine therapy.
A phase 1 trial treated 15 patients with breast cancer that spread to the spinal fluid using a vaccine made from their own immune cells. One patient is now more than three years from diagnosis.
Twenty-three years after a breast cancer diagnosis at 39, a survivor explains why her garage gym became a place to rebuild strength.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Leukemia Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
3 More Lung Cancer Breakthroughs From WCLC 2026
3
Lunsumio Plus Revlimid Delays Follicular Lymphoma Progression
4
Oncology Nurse Leader Brings Stem Cell Transplant Care Closer to Home
5